Literature DB >> 12708816

Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years.

G V McDonnell1, J Cabrera-Gomez, D B Calne, D K B Li, J Oger.   

Abstract

BACKGROUND: Subclinical multiple sclerosis (MS) has been identified incidentally at autopsy; apparently unaffected individuals with an affected twin have demonstrated magnetic resonance imaging (MRI) changes consistent with MS, and 'MRI relapses' are several times more common than clinical relapses. CASE DESCRIPTION: A 39-year-old, right-handed man underwent MRI and PET scanning in 1986 as a 'normal' control in a Parkinson's disease study, where his father was the proband. MRI indicated multiple areas of abnormal signal intensity in a periventricular and grey-white matter junction distribution. Repeated clinical evaluations over the next 10 years were unchanged until 1996, when he complained of progressive weakness of the right foot and clumsiness in the right hand. MRI now indicated a further area of high signal intensity in the right posterior cord at the level of C5/C6. There was mild pyramidal distribution weakness in the right leg with an extensor plantar response on the same side. Over the next five years there has been mild progression in weakness and fatigue and intermittent Lhermitte's phenomenon. At no stage has there been a history of relapse, cerebrospinal fluid examination was normal and evoked responses (visual and somatosensory) are normal.
CONCLUSION: This case demonstrates the phenomenon of subclinical MS, unusually supported by prolonged clinical and MRI follow-up. The patient eventually became symptomatic nine years after MRI diagnosis and is following a primary progressive course. Although MRI is known to be sensitive in identifying subclinical 'attacks', the pattern illustrated here may actually be quite typical of primary progressive MS and is compatible with the later onset seen in this subgroup of patients.

Entities:  

Mesh:

Year:  2003        PMID: 12708816     DOI: 10.1191/1352458503ms890cr

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

1.  Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome.

Authors:  D T Okuda; E M Mowry; B A C Cree; E C Crabtree; D S Goodin; E Waubant; D Pelletier
Journal:  Neurology       Date:  2011-01-26       Impact factor: 9.910

2.  The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis.

Authors:  J M Greer; M P Pender
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

3.  Discovery and disclosure of incidental findings in neuroimaging research.

Authors:  Judy Illes; Matthew P Kirschen; Kim Karetsky; Megan Kelly; Arnold Saha; John E Desmond; Thomas A Raffin; Gary H Glover; Scott W Atlas
Journal:  J Magn Reson Imaging       Date:  2004-11       Impact factor: 4.813

Review 4.  The radiologically isolated syndrome: look (again) before you treat.

Authors:  Rebecca Spain; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

5.  Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Authors:  Melih Tutuncu; Junger Tang; Nuhad Abou Zeid; Nilufer Kale; Daniel J Crusan; Elizabeth J Atkinson; Aksel Siva; Sean J Pittock; Istvan Pirko; B Mark Keegan; Claudia F Lucchinetti; John H Noseworthy; Moses Rodriguez; Brian G Weinshenker; Orhun H Kantarci
Journal:  Mult Scler       Date:  2012-06-26       Impact factor: 6.312

Review 6.  [Radiologically isolated syndrome: multiple sclerosis based solely on MRI findings?].

Authors:  J Sellner; L Schirmer; B Hemmer; M Mühlau
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

7.  Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis.

Authors:  Mio Nakamura; Mark Morris; Mirela Cerghet; Lonni Schultz; Stanton Elias
Journal:  Int J MS Care       Date:  2014

Review 8.  Unanticipated demyelinating pathology of the CNS.

Authors:  Darin T Okuda
Journal:  Nat Rev Neurol       Date:  2009-10-06       Impact factor: 42.937

9.  When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults?

Authors:  Mona Alkhawajah; Joel Oger
Journal:  Mult Scler Int       Date:  2011-05-17

10.  Is inflammation important in early PPMS? a longitudinal MRI study.

Authors:  G T Ingle; J Sastre-Garriga; D H Miller; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.